Ex Parte Kikuchi et al - Page 4


                 Appeal No.  2006-3084                                                          Page 4                   
                 Application No.  10/673,860                                                                             
                 2-fold higher than ATCC138691, and “AJ12036-derived strains which have                                  
                 retained this activity, but otherwise might not be identical, i.e. mutants.”  The                       
                 examiner agrees, but remains of the opinion “that there is not an adequate                              
                 description of the mutant strains that are encompassed.”  Answer, page 7,                               
                 emphasis removed.                                                                                       
                        The examiner acknowledges that the issue is not “[t]he ability to isolate,                       
                 or discover, new mutants of the AJ12036 strain . . . .”  Id.  Instead, the examiner                     
                 contends (id.) that AJ12036 mutants “which retain the ability of the parent strain                      
                 to have increased secretion of proteins, therefore, have not been described in                          
                 terms of their genetic structure.”  Id.  According to the examiner, since                               
                        [o]ne of skill in the art cannot envision the genetic alterations which                          
                        would leave intact this ability to secrete proteins at a higher level                            
                        than a wild type strain . . . [o]ne would not be able to envision the                            
                        identity of such mutants, since one does not even know the starting                              
                        structure, i.e. the genetic sequence or alteration responsible for the                           
                        activity of increased secretion in AJ12036, from which mutants are                               
                        derived.                                                                                         
                 Id.  We disagree.  As the examiner recognizes, methods of making mutants are                            
                 known in the art and appellants’ claimed mutants are derived from the deposited                         
                 Corynebacterium glutamicum AJ12036 (FERM BP-734).  Therefore, the starting                              
                 structure, i.e. the genetic sequence or alteration responsible for the activity of                      
                 increased secretion, is defined by the deposited microorganism.  As appellants                          
                 explain (Reply Brief, page 3), “[t]here is no requirement to ‘envision’ the structure                   
                 of the mutant since it has been deposited.”  As set forth in Enzo Biochem, Inc. v.                      
                 Gen-Probe Inc., 323 F.3d 956, 965, 63 USPQ2d 1609, 1614 (Fed. Cir. 2002),                               
                                                                                                                         
                 1 According to appellants’ specification (paragraph 27), Corynebacterium glutamicum AJ12036             
                 (FERM BP-734) bacterium “has the capacity of secretory production of heterologous proteins at           
                 least 2-3 fold higher than the parent strain (wild type strain) . . . .”                                




Page:  Previous  1  2  3  4  5  6  7  Next

Last modified: September 9, 2013